Cholinesterase inhibitors might alleviate methamphetamine-induced delusions, hallucinations and cognitive impairment, while reducing craving and addiction [2]

World Journal of Biological Psychiatry

Volumn 7, Issue 4, 2006, Pages 269-

  Martin Alisky, Joseph ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHOLINESTERASE INHIBITOR; DONEPEZIL; DOPAMINE; GALANTAMINE; METHAMPHETAMINE; NICOTINE; OLANZAPINE; RIVASTIGMINE;

AUTOPSY; BASAL GANGLION; COGNITIVE DEFECT; DELUSION; DRUG DEPENDENCE; HALLUCINATION; HUMAN; LETTER; NONHUMAN; PARKINSON DISEASE; PSYCHOSIS; WITHDRAWAL SYNDROME;

AUTOPSY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHOLINESTERASE INHIBITORS; COGNITION DISORDERS; DELUSIONS; DOPAMINE; HALLUCINATIONS; HUMANS; METHAMPHETAMINE; SUBSTANCE-RELATED DISORDERS;

EID: 33750432138     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970600947030     Document Type: Letter

References (5)

1. Fabbrini, G and Barbanti, P and Aurilia, C and Pauletti, C and Lenzi, GL and Meco, G. (2002) Donepezil in the treatment of hallucinations and delusions in Parkinson's disease Neurol Sci 23, pp. 41-43.
2. Hiranita, T and Nawata, Y and Sakimura, K and Anggadiredja, K and Yamamoto, T. (2006) Suppression of methamphetamine-seeking behavior by nicotinic agonists Proc Natl Acad Sci USA, 103, pp. 8523-8527.
3. MaidmentI, FoxC, BoustaniM. 2006. Cholinesterase inhibitors for Parkinson's disease dementia. Cochrane Database Syst Rev DOI: 10.1002/ 14651858.CD004747.pub2.
4. Misra, LK and Kofoed, L and Oesterheld, JR and Richards, GA. (2000) Olanzapine treatment of methamphetamine psychosis J Clin Psychopharmacol, 20, pp. 393-394.
5. Moszczynska, A and Fitzmaurice, P and Ang, L and Kalasinsky, KS and Schmunk, GA and Peretti, FJ and (2004) Why is parkinsonism not a feature of human methamphetamine users? Brain, 127, pp. 363-370.